CareTrust REIT, Inc. (CTRE)
NYSE: CTRE · IEX Real-Time Price · USD
25.35
+0.21 (0.84%)
At close: Jul 2, 2024, 4:00 PM
25.50
+0.15 (0.59%)
After-hours: Jul 2, 2024, 7:11 PM EDT

Company Description

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector.

As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas.

As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

CareTrust REIT, Inc.
CareTrust REIT logo
Country United States
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 17
CEO David M. Sedgwick

Contact Details

Address:
905 Calle Amanecer, Suite 300
San Clemente, California 92673
United States
Phone (949) 542-3140
Website caretrustreit.com

Stock Details

Ticker Symbol CTRE
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001590717
CUSIP Number 14174T107
ISIN Number US14174T1079
Employer ID 46-3999490
SIC Code 6798

Key Executives

Name Position
David M. Sedgwick Chief Executive Officer, President and Director
William M. Wagner Chief Financial Officer and Treasurer
James B. Callister Chief Investment Officer and Secretary
Eric Gillis Director of Asset Management
Lauren Beale Senior Vice President and Controller

Latest SEC Filings

Date Type Title
Jun 4, 2024 8-K Current Report
May 6, 2024 8-K Current Report
May 6, 2024 424B5 Filing
May 2, 2024 8-K Current Report
May 2, 2024 10-Q Quarterly Report
Apr 29, 2024 8-K Current Report
Mar 8, 2024 ARS Filing
Mar 8, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 8, 2024 DEF 14A Other definitive proxy statements
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals